Benefit of intravenous IgG replacement in hypogammaglobulinemic patients with chronic sinopulmonary disease

https://doi.org/10.1016/0002-9343(85)90006-3Get rights and content

Abstract

Seven patients with hypogammaglobulinemia and chronic sinopulmonary infections were treated with a preparation of intravenous gammaglobulin. In order to maintain levels of serum IgG at greater than 500 to 750 mg/dl four weeks after infusion, 0.6 g/kg was administered every month. Stable serum levels were achieved after three to eight months. After six to 12 months of this regimen, there was significant reduction in acute infections requiring hospitalization, amelioration of clinical and radiographic evidence of chronic maxillary sinusitis, and improvement in pulmonary symptoms and pulmonary function test results. The administration of increased amounts of IgG intravenously is of benefit in patients with chronic sinopulmonary infections.

References (18)

There are more references available in the full text version of this article.

Cited by (96)

  • Immunoglobulin treatment in primary antibody deficiency

    2011, International Journal of Antimicrobial Agents
    Citation Excerpt :

    Furthermore, the studies are limited by sample size and follow-up. None the less, the majority of these studies show that higher Ig dosage and IgG trough levels result in fewer infections and a reduced duration of the remaining disease episode [52,53,56–58,62,64,101,102]. The exact IgG trough level that will protect antibody-deficient patients against recurrent bacterial infection and progression to chronic lung damage remains uncertain.

View all citing articles on Scopus

This work was supported by the Medical Research Council of Canada.

View full text